Should probiotics be tested on ex vivo organ culture models

Gut Microbes

Volumn 3, Issue 5, 2012, Pages 442-448

  Tsilingiri, Katerina ^a   Rescigno, Maria ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Ex vivo organ culture; IBD; Postbiotics; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG SCREENING; ENTERITIS; EX VIVO STUDY; EXPLANT; HUMAN; INTESTINE MUCOSA; LACTOBACILLUS PARACASEI; NONHUMAN; ORGAN CULTURE; SALMONELLA;

EID: 84866041618     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.20885     Document Type: Article

References (26)

1. Jeppsson B, Mangell P, Thorlacius H. Use of probiotics as prophylaxis for postoperative infections. Nutrients 2011; 3:604-12; PMID:22254113; http://dx.doi.org/10.3390/nu3050604.
2. Ligaarden SC, Axelsson L, Naterstad K, Lydersen S, Farup PG. A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterol 2010; 10:16; PMID:20144246; http://dx.doi.org/10.1186/1471-230X-10-16.
3. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. J Clin Gastroenterol 2011; 45(Suppl):S139-44; PMID:21992953; http://dx.doi.org/10.1097/MCG.0b013e31822103f7.
4. Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, et al.; Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651-9; PMID:18279948; http://dx.doi.org/10.1016/S0140-6736(08)60207-X.
5. Cencic A, Langerholc T. Functional cell models of the gut and their applications in food microbiology--a review. Int J Food Microbiol 2010; 141(Suppl 1):S4-14; PMID:20444515; http://dx.doi.org/10.1016/j.ijfoodmicro.2010.03.026.
6. Schoeb TR, Bullard DC. Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases. Inflamm Bowel Dis 2012; PMID:22294506; http://dx.doi.org/10.1002/ibd.22892.
7. te Velde AA, Verstege MI, Hommes DW. Critical appraisal of the current practice in murine TNBSinduced colitis. Inflamm Bowel Dis 2006; 12:995-9; PMID:17012970; http://dx.doi.org/10.1097/01.mib.0000227817.54969.5e.
8. Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol 2011; 32:256-64; PMID:21565554; http://dx.doi.org/10.1016/j.it.2011.04.003.
9. Lee J, Mo JH, Katakura K, Alkalay I, Rucker AN, Liu YT, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006; 8:1327-36; PMID:17128265; http://dx.doi.org/10.1038/ncb1500.
10. Lee J, Gonzales-Navajas JM, Raz E. The "polarizing- tolerizing" mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 2008; 30:3-9; PMID:18026955; http://dx.doi.org/10.1007/s00281-007-0099-7.
11. Vicente-Suarez I, Brayer J, Villagra A, Cheng F, Sotomayor EM. TLR5 ligation by flagellin converts tolerogenic dendritic cells into activating antigen-presenting cells that preferentially induce T-helper 1 responses. Immunol Lett 2009; 125:114-8; PMID:19555720; http://dx.doi.org/10.1016/j.imlet.2009.06.007.
12. Borruel N, Casellas F, Antolín M, Llopis M, Carol M, Espíin E, et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 2003; 98:865-70; PMID:12738469; http://dx.doi.org/10.1111/j.1572-0241.2003.07384.x.
13. Schüller S, Lucas M, Kaper JB, Girón JA, Phillips AD. The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol 2009; 11:521-30; PMID:19134113; http://dx.doi.org/10.1111/j.1462-5822.2008.01275.x.
14. Dame MK, Bhagavathula N, Mankey C, DaSilva M, Paruchuri T, Aslam MN, et al. Human colon tissue in organ culture: preservation of normal and neoplastic characteristics. In Vitro Cell Dev Biol Anim 2010; 46:114-22; PMID:19915935; http://dx.doi.org/10.1007/s11626-009-9247-9.
15. Armbrecht HJ, Boltz MA, Kumar VB. Development of a vitamin D-responsive organ culture system for adult and old rat intestine. Dig Dis Sci 2002; 47:2831-8; PMID:12498308; http://dx.doi.org/10.1023/A:1021038129203.
16. Tsilingiri K, Barbosa T, Penna G, Caprioli F, Sonzogni A, Viale G, et al. Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model. Gut 2012; 61:1007-15; PMID:22301383; http://dx.doi.org/10.1136/gutjnl-2011-300971.
17. Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One 2009; 4:e7056; PMID:19756155; http://dx.doi.org/10.1371/journal.pone.0007056.
18. Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJ, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010; 298:G851-9; PMID:20224007; http://dx.doi.org/10.1152/ajpgi.00327.2009.
19. Möndel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, et al. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2009; 2:166-72; PMID:19129752; http://dx.doi.org/10.1038/mi.2008.77.
20. Subramani DB, Johansson ME, Dahlén G, Hansson GC. Lactobacillus and Bifidobacterium species do not secrete protease that cleaves the MUC2 mucin which organises the colon mucus. Benef Microbes 2010; 1:343-50; PMID:21831773; http://dx.doi.org/10.3920/BM2010.0039.
21. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008; 105:16731-6; PMID:18936492; http://dx.doi.org/10.1073/pnas.0804812105.
22. Na X, Kelly C. Probiotics in clostridium difficile Infection. J Clin Gastroenterol 2011; 45(Suppl):S154-8; PMID:21992956; http://dx.doi.org/10.1097/MCG.0b013e31822ec787.
23. Liu Z, Qin H, Yang Z, Xia Y, Liu W, Yang J, et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and postoperative infectious complications in colorectal cancer surgery - a double-blind study. Aliment Pharmacol Ther 2011; 33:50-63; PMID:21083585; http://dx.doi.org/10.1111/j.1365-2036.2010.04492.x.
24. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, doubleblind trial. Am J Transplant 2005; 5:125-30; PMID:15636620; http://dx.doi.org/10.1111/j.1600-6143.2004.00649.x.
25. Lembo-Fazio L, Nigro G, Noël G, Rossi G, Chiara F, Tsilingiri K, Rescigno M, Rasola A, Bernardini ML. Gadd45α activity is the principal effector of Shigella mitochondria-dependent epithelial cell death in vitro and ex vivo. Cell Death Dis 2011; 2:e122; PMID:21368893; http://dx.doi.org/10.1038/cddis.2011.4.
26. Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, et al. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012; 11:367-79; PMID:22380827; http://dx.doi.org/10.1586/erv.11.196.